| Views | |
|---|---|
| Development of a transcutaneous form of desloratadine | 32 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| Development of a transcutaneous form of desloratadine | 3 | 0 | 0 | 1 | 5 | 2 | 4 |
| Views | |
|---|---|
| Ageev_Development_24.pdf | 27 |
| Views | |
|---|---|
| United States | 10 |
| EU | 3 |
| India | 3 |
| Germany | 2 |
| Australia | 1 |
| Brazil | 1 |
| Canada | 1 |
| Jordan | 1 |
| Norway | 1 |
| Russia | 1 |
| Views | |
|---|---|
| Mountain View | 3 |
| Mumbai | 3 |
| Sacramento | 3 |
| Palo Alto | 2 |
| Amman | 1 |
| Dearborn | 1 |
| Haugesund | 1 |
| Mytishchi | 1 |
| Ottawa | 1 |
| Washington | 1 |